Industry News
Synchron pauses enrolment in its Stentrode trials over a problem with the implant's lead
Synchron has paused enrolment in trials of its updated, fully wireless Stentrode after a performance problem with the lead, the cable that carries signals from the Stentrode to the implanted electronics. The company says it chose to pause on its own and that no device-related safety issues have been found, and it is upgrading the whole system before restarting. WIRED reported that Synchron is also cutting jobs and scaling back in New York while building a San Diego team for a new device. Separately, the registry entry for its Canadian study lists it as terminated in September for insufficient recruitment.